Clinical value of haotirofiban combined with emergency coronary intervention in the treatment of acute myocardial infarction
好替罗非班联合急诊冠脉介入术治疗急性心肌梗死的临床价值

摘要

目的 探讨替罗非班联合急诊冠脉介入术治疗急性心肌梗死的临床效果。方法 选择2019年5月至2021年5月期间本院收治的110例急性心肌梗死患者，随机分为两组，分别给予急诊冠脉介入术治疗和替罗非班与急诊冠脉介入术联合治疗，对比两组临床效果，包括：治疗前后心功能变化及治疗后TIMI血流分级、心血管事件发生率、病死率情况。结果 与治疗前相比，两组治疗后心功能各项数据均有明显改善，且观察组优于对照组；与对照组相比，观察组TIMI血流分级情况更好，观察组心血管事件发生率更低（P<0.05）。结论 经替罗非班联合急诊冠脉介入术治疗后，急性心肌梗死患者心功能、TIMI血流分级改善情况更佳，临床应用价值高。

Abstract

Objective: To investigate the clinical effect of tirofiban combined with emergency coronary intervention in the treatment of acute myocardial infarction.
Methods: 110 patients with acute myocardial infarction treated in our hospital from May 2019 to may 2021 were randomly divided into two groups. They were treated with emergency coronary intervention and tirofiban combined with emergency coronary intervention respectively. The clinical effects of the two groups were compared, including changes of cardiac function before and after treatment, TIMI blood flow grade, incidence of cardiovascular events and mortality after treatment.
Results: Compared with before treatment, the data of cardiac function in both groups after treatment were significantly improved, and the observation group was better than the control group; compared with the control group, the TIMI blood flow classification in the observation group was better, and the incidence of cardiovascular events in the observation group rate was lower (P<0.05).
Conclusion  : After tirofiban combined with emergency coronary intervention, the improvement of cardiac function and TIMI blood flow classification in patients with acute myocardial infarction is better, and the clinical application value is high.